Canine Comprehensive Genomic Profiling (Canine CGP) test performs whole exome sequencing of canine tumors, investigating all common mutation types in over 20,257 coding genes across the canine genome

Canine CGP is the world’s largest, most comprehensive tumor genomic diagnostic test for dogs with cancer, providing unparalleled insights into tumor genomics to support personalized cancer management and effective treatment

Canine CGP provides genomics-based treatment recommendations for all targeted therapy, immunotherapy, chemotherapy and radiation therapy that are currently available for dog’s use, a first-of-its-kind test in veterinary medicine

• Validation: Canine CGP was validated using orthogonal methods under CLIA-accredited workflow.
• Sample type: Formalin-Fixed Paraffin-Embedded tissue (FFPE) & Fine Needle Aspirate (FNA) & Fresh frozen tissue
• Clinical actionability: Canine CGP enables comprehensive genomic profiling for canine cancer patients, providing highest chance to identify putative pathogenic mutations and clinical actionable biomarkers for novel and effective treatment strategies.
• Discovery potential: For researchers, our test offers an unprecedented deep dive into the genomic underpinning and background of both common and rare canine cancers.